Quantcast

Latest Anxiolytics Stories

2006-06-21 08:00:00

By Bill Berkrot NEW YORK -- An experimental insomnia drug being developed by Merck & Co. and Danish drug maker H. Lundbeck A/S showed promise in helping patients achieve deep sleep in small mid-stage clinical studies, the companies said on Wednesday. Statistically significant increases in deep sleep were seen with gaboxadol at all four tested doses compared to a placebo, but the drug appeared to be more effective at the higher 10 milligram, 15 mg, and 20 mg than at the lowest 5 mg dose,...

2006-05-09 11:55:00

By Sam Nelson CHICAGO (Reuters) - The burgeoning ethanol industry is changing the economic landscape of rural America, as companies pour billions of dollars into production plants in a race to meet demand and ease America's addiction to gasoline. Ethanol backers foresee vast vistas of corn fields churning out feedstock for the clean burning fuel additive running millions of cars in the United States, the world's largest consumer of energy. "Ethanol is a tremendous economic engine for rural...

2006-05-05 12:55:00

By Kim Dixon CHICAGO (Reuters) - U.S. Rep. Patrick Kennedy's statement that he used Sanofi-Aventis's sleep drug Ambien, to explain how he might have been involved in a late-night car crash, has led to renewed attention on the drug's possible side-effects. The Rhode Island Democrat had also taken the prescription nausea drug phenergan before crashing his car into a security barrier in Washington D.C. early Thursday morning. Nobody was hurt but the incident has intensified questioning about...

2006-03-15 00:55:00

By Kim Dixon CHICAGO -- Strange behavior by insomniacs taking prescription drugs, ranging from binge eating to having sex while asleep, have raised safety questions about anti-insomnia medications like Sanofi-Aventis' Ambien. Researchers in Minnesota are studying cases where insomniacs taking Ambien got up in the middle of the night, binged uncontrollably, then remembered nothing of their actions. The researchers expect to publish data shortly. Such sleep-induced side effects while on the...

2006-03-13 17:50:46

NEW YORK (Reuters Health) - A program designed to reduce inappropriate prescriptions for benzodiazepines, such as Xanax and Valium, had the unintended consequence of increasing racial disparities in access to care, according to a report in the Archives of Internal Medicine. "This is the first well-controlled study to show that health policies designed to reduce drug costs and abuse can increase racial disparities in access to effective care for those with chronic illnesses, like...

2005-12-11 09:26:18

Ambien, Lunesta and Sonata all have their pluses and minuses, study found HealthDay News -- No single sleeping pill stands out as the best, according to a U.S. review of the newer sleep aids on the market. The researchers reviewed 141 studies of the sleeping pills Sonata, Ambien, Lunesta and a Canadian brand called Imovane. These are all considered newer sleeping aids and are commonly prescribed for insomnia in place of older benzodiazepine sleeping aids such as Halcion, ProSom and Restoril....

2005-11-11 15:28:04

NEW YORK (Reuters Health) - While sedative drugs, such as Restoril and Ambien, may improve sleep in older people with insomnia, the risks of such therapy may outweigh the benefits, according to investigators in Canada. The findings are based on a review of 24 trials that included 2417 subjects aged 60 or older who were treated with so-called sedative hypnotic pills or inactive placebo pills for insomnia. The subjects received the assigned pills for at least five consecutive nights....

2005-07-14 17:00:00

Researchers outline five basic steps to help doctors identify and treat insomnia in elderly patients. This article is published in a special insomnia themed supplement of the Journal of the American Geriatrics Society. Researchers say insomnia is a common problem that warrants increased attention from doctors who care for older adults. The study presents a five-step approach to diagnose and manage insomnia in these patients. If followed, data shows that doctors could help to reduce sleep...

2005-06-25 10:07:53

In trial, ramelteon helped users doze off and sleep longer HealthDay News -- The investigational drug ramelteon reduced the time it took for people with chronic insomnia to fall asleep and also increased their total sleep time, according to the results of a Phase III study sponsored by the drug's maker, Takeda Pharmaceuticals. The study also found no evidence of rebound insomnia, next-day impairments or withdrawal effects after people stopped using the drug. The U.S. Food and Drug...

2005-06-20 22:38:45

Denver, CO, June 20, 2005 "“ Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.